View in EDS HTML Full Text PDF Full Text

A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma.

Saved in:
Bibliographic Details
Title: A nontandem novel compound chimeric antigen receptor redirected to target CD20‐CD19 positive B‐cell acute leukemias and B‐cell lymphoma.
Authors: DeStefano, Vincent M1 (AUTHOR), Wada, Masayuki1 (AUTHOR), Pinz, Kevin G1 (AUTHOR), Assi, Rita2 (AUTHOR), Zhang, Hongyu3 (AUTHOR), Wang, Weijia4 (AUTHOR), Zhang, Wenli3 (AUTHOR), Shah, Darshi1 (AUTHOR), Ma, Yupo1 (AUTHOR) yupo.ma@icellgene.com, Salman, Huda5 (AUTHOR) hsalman@iu.edu
Source: Clinical & Translational Medicine. Jul2024, Vol. 14 Issue 7, p1-6. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.1743